友邦保險(01299.HK)擬授出181.2萬個受限制股份認購單位
格隆匯4月2日丨友邦保險(01299.HK)公告,於2025年3月24日(即2025代理購股計劃的計劃年度("2025計劃年度")指定的登記期(於2025年3月3日開始)的最後1日),5,524名參與者已登記代理購股計劃,以於2025年5月1日至2026年4月30日期間每月購買股份。
根據參與者就2025計劃年度每月股份購買所示的供款總額及2025年3月24日的股價60.15港元,公司估計於2025計劃年度將向參與者授出合共1,812,056個受限制股份認購單位,使彼等有權於相關受限制股份認購單位歸屬後收取公司將予發行的合共1,812,056股股份。
董事會認爲,此等授出將通過讓代理持有公司股權來增強其歸屬感與敬業度,這符合代理購股計劃中有關促進和鼓勵獲選代理主管及代理長期持有友邦保險股份的計劃目的。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.